生酮饮食
肠道菌群
拟杆菌
癫痫
粪便
厚壁菌
生物
脆弱类杆菌
生理学
内科学
内分泌学
微生物学
免疫学
医学
细菌
遗传学
抗生素
神经科学
16S核糖体RNA
作者
Jing Wang,Lijuan Huang,Hua Li,Guohong Chen,Liming Yang,Dong Wang,Ho Jae Han,Zheng Guo,Xu Wang,Jianmin Liang,Weijie He,Fang Fang,Jianxiang Liao,Dan Sun
标识
DOI:10.3389/fneur.2023.1237255
摘要
The ketogenic diet (KD) has shown excellent performance in the treatment of refractory epilepsy, but how it works is not yet fully understood. Gut microbiota is associated with various neurological disorders through the brain-gut axis. Different dietary patterns have different effects on the composition and function of gut microbiota. Here, by analyzing fecal samples from some patients with mitochondrial epilepsy before and after KD treatment through 16SrRNA sequencing, we found that KD intervention reduced the abundance of Firmicutes in the patient's gut, while the abundance of Bacteroidota increased in the KD group. LefSe analysis showed that Actinobacteriota, Phascolarctobacterium had significant advantages in the control group, while Bacteroides increased significantly after KD intervention, especially Bacteroides fragilis. Functional analysis showed that there were significant differences in 12 pathways in level 3. These changes suggest that KD can change the composition and diversity of the gut microbiota in patients and affect their function. Changes in specific bacterial groups in the gut may serve as biomarkers for the therapeutic effects of KD on epilepsy.
科研通智能强力驱动
Strongly Powered by AbleSci AI